Lantern Pharma (NASDAQ:LTRN) Coverage Initiated by Analysts at Lake Street Capital
Lake Street Capital initiated coverage on shares of Lantern Pharma (NASDAQ:LTRN – Free Report) in a report released on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $25.00 target price on the stock. Lantern Pharma Trading Down 8.0 % LTRN opened at $2.99 on Wednesday. The stock has a market […]
